Evidence map›Paper›PMID 41769476›Full record

ArticleCureus2026

Cefdinir-Associated Myopericarditis.

Chirag Lodha, Bharath Subramanian, Matthew Bajaj, Patrick J Rogers, Eric J Basile, Luke Casals, Krunal Shukla, Jonathan Van Name, Afrin Naz

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chirag LodhaInternal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.
Bharath SubramanianMedicine, USF Health, Tampa, USA.
Matthew BajajInternal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.
Patrick J RogersInternal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.
Eric J BasileCardiovascular Disease, University of South Florida Morsani College of Medicine, Tampa, USA.
Luke CasalsInternal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.
Krunal ShuklaInternal Medicine, University of Florida College of Medicine, Gainesville, USA.
Jonathan Van NameInternal Medicine, University of Florida College of Medicine, Gainesville, USA.
Afrin NazInternal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefdinir is a third-generation cephalosporin with a wide variety of indications and a strong safety profile. A 24-year-old man began taking cefdinir for an uncomplicated urinary tract infection. Two days later, he began experiencing pleuritic, sharp chest pain and diarrhea and was shown to have mildly elevated troponins. Due to the pleuritic nature of his chest pain improving when leaning forward, as well as elevated troponins and a new small pericardial effusion on echocardiogram, he was diagnosed with myopericarditis thought to be secondary to cefdinir. Cefdinir was subsequently held with diarrhea and chest pain improving shortly afterwards. He was started on ibuprofen 600mg TID for two weeks, as well as colchicine 0.5mg daily for six weeks. The patient finished his treatment regimen and does not endorse recurrence of his chest pain or any symptoms of heart failure, such as orthopnea, lower extremity edema, or shortness of breath.

Indexed as

cardiologycefdinirdrug-related side effects and adverse reactionsmyopericarditispericarditis

Identifiers

PMID41769476
PMCPMC12945452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.